Anze Yu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
Papers in
- Surgery 9
- Adrenal and Paraganglionic Tumors 5
- Bladder and Urothelial Cancer Treatments 4
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Co-authors
- Xiongbing Zu (9 shared papers)Jiao Hu (8 shared papers)Jinbo Chen (6 shared papers)Huihuang Li (6 shared papers)Belaydi Othmane (5 shared papers)Wenbiao Ren (4 shared papers)Minfeng Chen (2 shared papers)Guanghui Gong (2 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Frontiers in Immunology (2 papers)iScience (1 paper)BMC Medicine (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Anze Yu
24 papers receiving 670 citations
Anze Yu's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 141
- Pulmonary and Respiratory Medicine 171
- Immunology 102
- Oncology 121
- Molecular Biology 251
Countries citing papers authored by Anze Yu
This map shows the geographic impact of Anze Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anze Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anze Yu more than expected).
Fields of papers citing papers by Anze Yu
This network shows the impact of papers produced by Anze Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anze Yu. The network helps show where Anze Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anze Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer Hit paper breakdown → | 2021 | 260 |
| 2 | 2021 | 88 | |
| 3 | 2018 | 61 | |
| 4 | 2021 | 56 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 21 | |
| 7 | 2023 | 19 | |
| 8 | CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade. | 2020 | 19 |
| 9 | 2023 | 16 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 15 | |
| 12 | 2018 | 14 | |
| 13 | 2021 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2024 | 8 | |
| 17 | 2020 | 8 | |
| 18 | 2020 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2025 | 2 |
About Anze Yu
Anze Yu is a scholar working on Surgery, Molecular Biology, Oncology, Immunology and Cancer Research, having authored 25 papers that have together received 673 indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Ferroptosis and cancer prognosis (3 papers), CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (3 papers), Immunotherapy and Immune Responses (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (141 citations), Pulmonary and Respiratory Medicine (171 citations), Immunology (102 citations), Oncology (121 citations) and Molecular Biology (251 citations). Anze Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiongbing Zu, Jiao Hu, Jinbo Chen, Huihuang Li, Belaydi Othmane, Wenbiao Ren, Minfeng Chen, Guanghui Gong, Dongxu Qiu and Peihua Liu. Their work appears in journals such as Frontiers in Oncology, Journal for ImmunoTherapy of Cancer, Frontiers in Immunology, iScience and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.